- Home
- BCLI vs SWVL Comparison
BCLI vs SWVL Comparison
Compare BCLI & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- SWVL
- Stock Information
- Founded
- BCLI 2000
- SWVL 2017
- Country
- BCLI United States
- SWVL United Arab Emirates
- Employees
- BCLI N/A
- SWVL N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- SWVL Business Services
- Sector
- BCLI Health Care
- SWVL Consumer Discretionary
- Exchange
- BCLI Nasdaq
- SWVL Nasdaq
- Market Cap
- BCLI 9.8M
- SWVL 44.5M
- IPO Year
- BCLI N/A
- SWVL N/A
- Fundamental
- Price
- BCLI $1.20
- SWVL $4.79
- Analyst Decision
- BCLI Strong Buy
- SWVL
- Analyst Count
- BCLI 1
- SWVL 0
- Target Price
- BCLI $30.00
- SWVL N/A
- AVG Volume (30 Days)
- BCLI 432.6K
- SWVL 22.8K
- Earning Date
- BCLI 08-13-2025
- SWVL 07-22-2025
- Dividend Yield
- BCLI N/A
- SWVL N/A
- EPS Growth
- BCLI N/A
- SWVL N/A
- EPS
- BCLI N/A
- SWVL N/A
- Revenue
- BCLI N/A
- SWVL $17,207,362.00
- Revenue This Year
- BCLI N/A
- SWVL N/A
- Revenue Next Year
- BCLI N/A
- SWVL N/A
- P/E Ratio
- BCLI N/A
- SWVL N/A
- Revenue Growth
- BCLI N/A
- SWVL N/A
- 52 Week Low
- BCLI $0.72
- SWVL $2.40
- 52 Week High
- BCLI $6.45
- SWVL $8.05
- Technical
- Relative Strength Index (RSI)
- BCLI 51.65
- SWVL 64.82
- Support Level
- BCLI $1.17
- SWVL $4.08
- Resistance Level
- BCLI $1.32
- SWVL $4.89
- Average True Range (ATR)
- BCLI 0.07
- SWVL 0.47
- MACD
- BCLI 0.00
- SWVL 0.07
- Stochastic Oscillator
- BCLI 60.00
- SWVL 91.60
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.